For some degree of consistency, Bregs can be defined functionally based on their ability to produce suppressive and anti-inflammatory cytokines (IL-10, TGFβ, and IL-35) that suppress pro-inflammatory or cytotoxic anti-tumour cells, and we have used this format to describe Bregs in a cancer setting. This evidence concerns the gene TGFB1 and cancer.